computed tomographic angiography showing bilateral pulmonary embolism [ Figure 1 ], as well as the Doppler ultrasonographic evidence of venous thrombosis in both lower extremities. Anticoagulation therapy by enoxaparin was initiated. On 2 nd day of admission, the flow velocity of LVOT was 454 cm/s with a transvalvular pressure gradient of 83 mmHg [ Figure 2a ]. In addition, parasternal long-axis Mmode echocardiography across the mitral valve showed systolic anterior motion (SAM) of the mitral valve leaflet [ Figure 3a ]. Re-examination of arterial blood gas analysis on the 3 rd day showed normalization of hypoxemia and systemic hypotension. Serial echocardiography performed on the 6 th , 13 th , and 21 st day revealed a gradual decrease of LVOT velocity, as well as the transvalvular pressure gradient [ Figure 2b Figure 4 : The dynamic changes in left ventricular outflow tract velocity and pressure gradient (left) and changes in right ventricular and atrial diameter (right) from symptom-onset. Note that on the 1 st day of symptom-onset, right atrial diameter was not measured discussion LVOT obstruction can independently result from various clinical settings such as LV hypertrophy (hypertension or sigmoid septum), reduced LV chamber size (dehydration, bleeding, or diuresis), mitral valve abnormalities (redundant, long anterior leaflet), hypercontractility (stress, anxiety, or inotropic agents such as dobutamine), [1] and ST-elevation myocardial infarction. [2, 3] Acute pulmonary embolism is a rare cause of LVOT obstruction. This patient had a history of nonobstructive hypertrophic cardiomyopathy with thickened interventricular septum. Acute pulmonary embolism usually leads to a significant increase in the right ventricular pressure load and leftward deviation of interventricular septum, which may further aggravate LVOT obstruction. The bloodstream causes drag forces and a Venturi effect on the anterior mitral leaflet, which results in SAM of the anterior mitral leaflet. This movement results in the anterior mitral leaflet contacting the septum for a period of systole, effectively obstructing the path of left ventricular outflow. [1] Dynamic LVOT obstruction can mimic cardiogenic shock in an acute-care setting. [4] Therefore, hypertrophic cardiomyopathy patients with pulmonary embolism are also at high risk of sudden death. More active anticoagulation therapy should be given to hypertrophic cardiomyopathy patients with high-risk factors of pulmonary embolism.
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